Table 2.
Variables | Exercise group | Dopamine agonists group | Placebo group |
---|---|---|---|
Sleep Diary |
|
|
|
Baseline |
7.69±5.51 |
10.28±2.87 |
8.42±5.09 |
6-m post |
7.30±4.13 |
5.85±3.71† |
8.85±4.09 |
Δ Change |
−0.71±3.22 |
- 4.42±3.10#¶ |
0.42±2.7 |
95% CI of Δ change |
−2.49 to 1.07 |
−7.28 to −1.56 |
2.91 to −2.07 |
Epworth Sleepiness Scale |
|
|
|
Baseline |
5.15±2.54 |
7.85±5.24 |
8.71±5.37 |
6-m post |
5.15±2.47 |
5.42±1.98 |
8.42±4.92 |
Δ Change |
−0.35±2.73 |
−2.42±5.38 |
- 0.28±4.19 |
95% CI of Δ change |
−1.85 to 1.15 |
−7.39 to 2.55 |
−4.15 to 3.59 |
Zung Depression Scale |
|
|
|
Baseline |
43.45±8.06 |
46.85±13.49 |
37.85±12.15 |
6-m post |
35.84±6.38†# |
39.42±4.35 |
43.71±11.17†¶ |
Δ Change |
−8.28±7.91# |
−7.42±10.34# |
5.85±6.41 |
95% CI of Δ change |
−12.60 to −3.91 |
−16.96 to 2.12 |
11.70 to −0.07 |
IRLS score |
|
|
|
Baseline |
25.14±9.09 |
24.14±5.55 |
19.71±7.49 |
6-m post |
13.42±11.28† |
11.57±7.84† |
18.57±10.65 |
Δ Change |
−13.12±8.59# |
- 12.57±5.31# |
- 1.14±8.43 |
95% CI of Δ change |
−17.87 to −8.37 |
−17.47 to −7.67 |
−8.93 to 6.65 |
SF-36 MCS score |
|
|
|
Baseline |
61.1±22.0 |
39.1±23.8 |
68.1±19.1 |
6-m post |
70.4±18.7 |
63.0±17.0† |
65.0±21.9 |
Δ Change |
9.3±26.7 |
23.8±14.1 |
3.1±9.8 |
95% CI of Δ change |
24.1 to 5.4 |
36.9 to 10.7 |
5.9 to −12.2 |
SF-36 PCS score |
|
|
|
Baseline |
64.9±18.6 |
48.7±21.0 |
64.4±22.5 |
6-m post |
76.4±15.6† |
68.8±19.2† |
70.5±26.5 |
Δ Change |
11.5±18.4 |
20.1±6.0 |
6.1±5.7 |
95% CI of Δ change | 21.7 to 1.2 | 25.7 to 14.5 | 20.2 to −7.9 |
All data are mean ± SD. Abbreviations: IRLS International restless legs syndrome severity scale, SF-36 Self reported quality of life questionnaire, MCS Mental component summary, PCS Physical component summary.
#Significantly different than placebo group.
¶Significantly different than exercise group.
†Significantly different from the respective baseline value.